Chemicals - Specialty
Compare Stocks
5 / 10Stock Comparison
CNEY vs GPRE vs REX vs ALTO vs AMTX
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Chemicals - Specialty
Oil & Gas Refining & Marketing
CNEY vs GPRE vs REX vs ALTO vs AMTX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty | Oil & Gas Refining & Marketing |
| Market Cap | $4M | $1.15B | $1.60B | $351M | $213M |
| Revenue (TTM) | $87M | $1.94B | $651M | $918M | $209M |
| Net Income (TTM) | $-25M | $-15M | $50M | $13M | $-74M |
| Gross Margin | -8.6% | 1.8% | 12.7% | 3.8% | 3.4% |
| Operating Margin | -26.1% | 1.2% | 8.6% | 0.8% | -13.4% |
| Forward P/E | — | 46.6x | 62.8x | 15.4x | — |
| Total Debt | $3M | $508M | $21M | $98M | $318M |
| Cash & Equiv. | $391K | $182M | $196M | $26M | $5M |
CNEY vs GPRE vs REX vs ALTO vs AMTX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 21 | May 26 | Return |
|---|---|---|---|
| CN Energy Group. In… (CNEY) | 100 | 0.4 | -99.6% |
| Green Plains Inc. (GPRE) | 100 | 65.0 | -35.0% |
| REX American Resour… (REX) | 100 | 310.5 | +210.5% |
| Alto Ingredients, I… (ALTO) | 100 | 70.1 | -29.9% |
| Aemetis, Inc. (AMTX) | 100 | 31.7 | -68.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CNEY vs GPRE vs REX vs ALTO vs AMTX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CNEY plays a supporting role in this comparison — it may shine differently against other peers.
GPRE lags the leaders in this set but could rank higher in a more targeted comparison.
REX is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 464.7% 10Y total return vs AMTX's 31.1%
- Lower volatility, beta 0.36, Low D/E 3.3%, current ratio 8.64x
- 7.7% margin vs AMTX's -35.4%
- 6.7% ROA vs AMTX's -29.3%, ROIC 11.4% vs -70.3%
ALTO carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 0.30, yield 0.4%
- Rev growth -4.9%, EPS growth 119.5%, 3Y rev CAGR -11.8%
- Beta 0.30, yield 0.4%, current ratio 2.64x
- -4.9% revenue growth vs CNEY's -30.2%
Among these 5 stocks, AMTX doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -4.9% revenue growth vs CNEY's -30.2% | |
| Value | Better valuation composite | |
| Quality / Margins | 7.7% margin vs AMTX's -35.4% | |
| Stability / Safety | Beta 0.30 vs AMTX's 1.46 | |
| Dividends | 0.4% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +427.8% vs CNEY's -85.4% | |
| Efficiency (ROA) | 6.7% ROA vs AMTX's -29.3%, ROIC 11.4% vs -70.3% |
CNEY vs GPRE vs REX vs ALTO vs AMTX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CNEY vs GPRE vs REX vs ALTO vs AMTX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
REX leads in 3 of 6 categories
CNEY leads 0 • GPRE leads 0 • ALTO leads 0 • AMTX leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
REX leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GPRE is the larger business by revenue, generating $1.9B annually — 22.4x CNEY's $87M. REX is the more profitable business, keeping 7.7% of every revenue dollar as net income compared to AMTX's -35.4%. On growth, AMTX holds the edge at +27.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $87M | $1.9B | $651M | $918M | $209M |
| EBITDAEarnings before interest/tax | -$19M | $122M | $67M | $33M | -$21M |
| Net IncomeAfter-tax profit | -$25M | -$15M | $50M | $13M | -$74M |
| Free Cash FlowCash after capex | -$4M | $90M | $18M | $9M | -$38M |
| Gross MarginGross profit ÷ Revenue | -8.6% | +1.8% | +12.7% | +3.8% | +3.4% |
| Operating MarginEBIT ÷ Revenue | -26.1% | +1.2% | +8.6% | +0.8% | -13.4% |
| Net MarginNet income ÷ Revenue | -29.1% | -0.8% | +7.7% | +1.5% | -35.4% |
| FCF MarginFCF ÷ Revenue | -4.7% | +4.7% | +2.7% | +0.9% | -18.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.4% | -25.9% | +0.4% | -1.9% | +27.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +94.2% | +134.2% | +2.9% | +149.1% | +29.8% |
Valuation Metrics
Evenly matched — CNEY and GPRE and ALTO each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 28.4x trailing earnings, ALTO trades at a 4% valuation discount to REX's 29.5x P/E. On an enterprise value basis, ALTO's 12.8x EV/EBITDA is more attractive than GPRE's 103.8x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4M | $1.1B | $1.6B | $351M | $213M |
| Enterprise ValueMkt cap + debt − cash | $7M | $1.5B | $1.4B | $423M | $526M |
| Trailing P/EPrice ÷ TTM EPS | -0.03x | -9.14x | 29.50x | 28.38x | -2.44x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 46.62x | 62.81x | 15.39x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.55x | — | — |
| EV / EBITDAEnterprise value multiple | — | 103.82x | 16.60x | 12.84x | — |
| Price / SalesMarket cap ÷ Revenue | 0.11x | 0.55x | 2.50x | 0.38x | 1.02x |
| Price / BookPrice ÷ Book value/share | 0.00x | 1.44x | 2.67x | 1.40x | — |
| Price / FCFMarket cap ÷ FCF | — | 17.84x | — | 40.58x | — |
Profitability & Efficiency
REX leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
REX delivers a 7.7% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $-25 for CNEY. REX carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to GPRE's 0.66x. On the Piotroski fundamental quality scale (0–9), REX scores 5/9 vs CNEY's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -24.9% | -2.0% | +7.7% | +6.0% | — |
| ROA (TTM)Return on assets | -23.5% | -1.0% | +6.7% | +3.4% | -29.3% |
| ROICReturn on invested capital | -8.2% | -5.2% | +11.4% | +1.9% | -70.3% |
| ROCEReturn on capital employed | -11.0% | -6.2% | +10.1% | +2.3% | -19.0% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 5 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.03x | 0.66x | 0.03x | 0.40x | — |
| Net DebtTotal debt minus cash | $3M | $326M | -$175M | $72M | $313M |
| Cash & Equiv.Liquid assets | $390,706 | $182M | $196M | $26M | $5M |
| Total DebtShort + long-term debt | $3M | $508M | $21M | $98M | $318M |
| Interest CoverageEBIT ÷ Interest expense | -29.77x | -0.08x | — | -0.93x | -0.27x |
Total Returns (Dividends Reinvested)
REX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in REX five years ago would be worth $34,996 today (with dividends reinvested), compared to $54 for CNEY. Over the past 12 months, ALTO leads with a +427.8% total return vs CNEY's -85.4%. The 3-year compound annual growth rate (CAGR) favors REX at 50.8% vs CNEY's -51.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +11.9% | +60.1% | +50.2% | +70.7% | +96.2% |
| 1-Year ReturnPast 12 months | -85.4% | +336.6% | +147.6% | +427.8% | +140.0% |
| 3-Year ReturnCumulative with dividends | -88.4% | -46.8% | +243.1% | +233.8% | +37.4% |
| 5-Year ReturnCumulative with dividends | -99.5% | -48.5% | +250.0% | -21.2% | -76.1% |
| 10-Year ReturnCumulative with dividends | -99.6% | +21.3% | +464.7% | +6.8% | +31.1% |
| CAGR (3Y)Annualised 3-year return | -51.2% | -19.0% | +50.8% | +49.5% | +11.2% |
Risk & Volatility
Evenly matched — REX and ALTO each lead in 1 of 2 comparable metrics.
Risk & Volatility
ALTO is the less volatile stock with a 0.30 beta — it tends to amplify market swings less than AMTX's 1.46 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. REX currently trades 91.2% from its 52-week high vs CNEY's 9.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.57x | 1.22x | 0.36x | 0.30x | 1.46x |
| 52-Week HighHighest price in past year | $7.36 | $18.94 | $53.36 | $5.99 | $3.80 |
| 52-Week LowLowest price in past year | $0.31 | $3.39 | $19.44 | $0.80 | $1.22 |
| % of 52W HighCurrent price vs 52-week peak | +9.6% | +86.9% | +91.2% | +75.8% | +82.1% |
| RSI (14)Momentum oscillator 0–100 | 54.5 | 54.3 | 59.1 | 61.1 | 58.2 |
| Avg Volume (50D)Average daily shares traded | 643K | 1.5M | 204K | 2.1M | 1.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: GPRE as "Buy", REX as "Buy", ALTO as "Buy", AMTX as "Buy". Consensus price targets imply 23.3% upside for REX (target: $60) vs -43.9% for AMTX (target: $2). ALTO is the only dividend payer here at 0.37% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $13.80 | $60.00 | $3.50 | $1.75 |
| # AnalystsCovering analysts | — | 20 | 3 | 2 | 7 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.4% | — |
| Dividend StreakConsecutive years of raises | — | 0 | — | 0 | — |
| Dividend / ShareAnnual DPS | — | — | — | $0.02 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.6% | +0.9% | 0.0% | 0.0% |
REX leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 2 categories are tied.
CNEY vs GPRE vs REX vs ALTO vs AMTX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CNEY or GPRE or REX or ALTO or AMTX a better buy right now?
For growth investors, Alto Ingredients, Inc.
(ALTO) is the stronger pick with -4. 9% revenue growth year-over-year, versus -30. 2% for CN Energy Group. Inc. (CNEY). Alto Ingredients, Inc. (ALTO) offers the better valuation at 28. 4x trailing P/E (15. 4x forward), making it the more compelling value choice. Analysts rate Green Plains Inc. (GPRE) a "Buy" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CNEY or GPRE or REX or ALTO or AMTX?
On trailing P/E, Alto Ingredients, Inc.
(ALTO) is the cheapest at 28. 4x versus REX American Resources Corporation at 29. 5x. On forward P/E, Alto Ingredients, Inc. is actually cheaper at 15. 4x.
03Which is the better long-term investment — CNEY or GPRE or REX or ALTO or AMTX?
Over the past 5 years, REX American Resources Corporation (REX) delivered a total return of +250.
0%, compared to -99. 5% for CN Energy Group. Inc. (CNEY). Over 10 years, the gap is even starker: REX returned +464. 7% versus CNEY's -99. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CNEY or GPRE or REX or ALTO or AMTX?
By beta (market sensitivity over 5 years), Alto Ingredients, Inc.
(ALTO) is the lower-risk stock at 0. 30β versus Aemetis, Inc. 's 1. 46β — meaning AMTX is approximately 380% more volatile than ALTO relative to the S&P 500. On balance sheet safety, REX American Resources Corporation (REX) carries a lower debt/equity ratio of 3% versus 66% for Green Plains Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CNEY or GPRE or REX or ALTO or AMTX?
By revenue growth (latest reported year), Alto Ingredients, Inc.
(ALTO) is pulling ahead at -4. 9% versus -30. 2% for CN Energy Group. Inc. (CNEY). On earnings-per-share growth, the picture is similar: Alto Ingredients, Inc. grew EPS 119. 5% year-over-year, compared to -39. 5% for Green Plains Inc.. Over a 3-year CAGR, CNEY leads at -4. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CNEY or GPRE or REX or ALTO or AMTX?
REX American Resources Corporation (REX) is the more profitable company, earning 9.
1% net margin versus -37. 0% for Aemetis, Inc. — meaning it keeps 9. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: REX leads at 10. 0% versus -30. 9% for CNEY. At the gross margin level — before operating expenses — REX leads at 14. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CNEY or GPRE or REX or ALTO or AMTX more undervalued right now?
On forward earnings alone, Alto Ingredients, Inc.
(ALTO) trades at 15. 4x forward P/E versus 62. 8x for REX American Resources Corporation — 47. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for REX: 23. 3% to $60. 00.
08Which pays a better dividend — CNEY or GPRE or REX or ALTO or AMTX?
In this comparison, ALTO (0.
4% yield) pays a dividend. CNEY, GPRE, REX, AMTX do not pay a meaningful dividend and should not be held primarily for income.
09Is CNEY or GPRE or REX or ALTO or AMTX better for a retirement portfolio?
For long-horizon retirement investors, REX American Resources Corporation (REX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
36), +464. 7% 10Y return). Both have compounded well over 10 years (REX: +464. 7%, AMTX: +31. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CNEY and GPRE and REX and ALTO and AMTX?
These companies operate in different sectors (CNEY (Basic Materials) and GPRE (Basic Materials) and REX (Basic Materials) and ALTO (Basic Materials) and AMTX (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.